255 related articles for article (PubMed ID: 31541193)
21. Overview of the Development of Glutaminase Inhibitors: Achievements and Future Directions.
Xu X; Meng Y; Li L; Xu P; Wang J; Li Z; Bian J
J Med Chem; 2019 Feb; 62(3):1096-1115. PubMed ID: 30148361
[TBL] [Abstract][Full Text] [Related]
22. Aging Reduces an ERRalpha-Directed Mitochondrial Glutaminase Expression Suppressing Glutamine Anaplerosis and Osteogenic Differentiation of Mesenchymal Stem Cells.
Huang T; Liu R; Fu X; Yao D; Yang M; Liu Q; Lu WW; Wu C; Guan M
Stem Cells; 2017 Feb; 35(2):411-424. PubMed ID: 27501743
[TBL] [Abstract][Full Text] [Related]
23. Two Faces of Glutaminase GLS2 in Carcinogenesis.
Buczkowska J; Szeliga M
Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067269
[TBL] [Abstract][Full Text] [Related]
24. Nuclear Translocation of Glutaminase GLS2 in Human Cancer Cells Associates with Proliferation Arrest and Differentiation.
López de la Oliva AR; Campos-Sandoval JA; Gómez-García MC; Cardona C; Martín-Rufián M; Sialana FJ; Castilla L; Bae N; Lobo C; Peñalver A; García-Frutos M; Carro D; Enrique V; Paz JC; Mirmira RG; Gutiérrez A; Alonso FJ; Segura JA; Matés JM; Lubec G; Márquez J
Sci Rep; 2020 Feb; 10(1):2259. PubMed ID: 32042057
[TBL] [Abstract][Full Text] [Related]
25. Identification and characterization of a novel glutaminase inhibitor.
Cederkvist H; Kolan SS; Wik JA; Sener Z; Skålhegg BS
FEBS Open Bio; 2022 Jan; 12(1):163-174. PubMed ID: 34698439
[TBL] [Abstract][Full Text] [Related]
26. The glutaminase inhibitor telaglenastat enhances the antitumor activity of signal transduction inhibitors everolimus and cabozantinib in models of renal cell carcinoma.
Emberley E; Pan A; Chen J; Dang R; Gross M; Huang T; Li W; MacKinnon A; Singh D; Sotirovska N; Steggerda SM; Wang T; Parlati F
PLoS One; 2021; 16(11):e0259241. PubMed ID: 34731180
[TBL] [Abstract][Full Text] [Related]
27. Brain Tumor Stem Cell Dependence on Glutaminase Reveals a Metabolic Vulnerability through the Amino Acid Deprivation Response Pathway.
Restall IJ; Cseh O; Richards LM; Pugh TJ; Luchman HA; Weiss S
Cancer Res; 2020 Dec; 80(24):5478-5490. PubMed ID: 33106333
[TBL] [Abstract][Full Text] [Related]
28. Recent Development of Small Molecule Glutaminase Inhibitors.
Song M; Kim SH; Im CY; Hwang HJ
Curr Top Med Chem; 2018; 18(6):432-443. PubMed ID: 29793408
[TBL] [Abstract][Full Text] [Related]
29. Glutamine drives glutathione synthesis and contributes to radiation sensitivity of A549 and H460 lung cancer cell lines.
Sappington DR; Siegel ER; Hiatt G; Desai A; Penney RB; Jamshidi-Parsian A; Griffin RJ; Boysen G
Biochim Biophys Acta; 2016 Apr; 1860(4):836-43. PubMed ID: 26825773
[TBL] [Abstract][Full Text] [Related]
30. Glutaminase 1 regulates the release of extracellular vesicles during neuroinflammation through key metabolic intermediate alpha-ketoglutarate.
Wu B; Liu J; Zhao R; Li Y; Peer J; Braun AL; Zhao L; Wang Y; Tong Z; Huang Y; Zheng JC
J Neuroinflammation; 2018 Mar; 15(1):79. PubMed ID: 29540215
[TBL] [Abstract][Full Text] [Related]
31. Multiomics Analysis Reveals that GLS and GLS2 Differentially Modulate the Clinical Outcomes of Cancer.
Saha SK; Islam SMR; Abdullah-Al-Wadud M; Islam S; Ali F; Park KS
J Clin Med; 2019 Mar; 8(3):. PubMed ID: 30871151
[TBL] [Abstract][Full Text] [Related]
32. Design and evaluation of novel glutaminase inhibitors.
McDermott LA; Iyer P; Vernetti L; Rimer S; Sun J; Boby M; Yang T; Fioravanti M; O'Neill J; Wang L; Drakes D; Katt W; Huang Q; Cerione R
Bioorg Med Chem; 2016 Apr; 24(8):1819-39. PubMed ID: 26988803
[TBL] [Abstract][Full Text] [Related]
33. Glutamine metabolism via glutaminase 1 in autosomal-dominant polycystic kidney disease.
Soomro I; Sun Y; Li Z; Diggs L; Hatzivassiliou G; Thomas AG; Rais R; Parker SJ; Slusher BS; Kimmelman AC; Somlo S; Skolnik EY
Nephrol Dial Transplant; 2018 Aug; 33(8):1343-1353. PubMed ID: 29420817
[TBL] [Abstract][Full Text] [Related]
34. The role of glutaminase in cancer.
Masisi BK; El Ansari R; Alfarsi L; Rakha EA; Green AR; Craze ML
Histopathology; 2020 Mar; 76(4):498-508. PubMed ID: 31596504
[TBL] [Abstract][Full Text] [Related]
35. Opposing roles of glutaminase isoforms in determining glioblastoma cell phenotype.
Szeliga M; Albrecht J
Neurochem Int; 2015 Sep; 88():6-9. PubMed ID: 25529918
[TBL] [Abstract][Full Text] [Related]
36. Knock-down of glutaminase 2 expression decreases glutathione, NADH, and sensitizes cervical cancer to ionizing radiation.
Xiang L; Xie G; Liu C; Zhou J; Chen J; Yu S; Li J; Pang X; Shi H; Liang H
Biochim Biophys Acta; 2013 Dec; 1833(12):2996-3005. PubMed ID: 23954443
[TBL] [Abstract][Full Text] [Related]
37. Glutaminase-1 stimulates the proliferation, migration, and survival of human endothelial cells.
Peyton KJ; Liu XM; Yu Y; Yates B; Behnammanesh G; Durante W
Biochem Pharmacol; 2018 Oct; 156():204-214. PubMed ID: 30144404
[TBL] [Abstract][Full Text] [Related]
38. Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition.
Jacque N; Ronchetti AM; Larrue C; Meunier G; Birsen R; Willems L; Saland E; Decroocq J; Maciel TT; Lambert M; Poulain L; Hospital MA; Sujobert P; Joseph L; Chapuis N; Lacombe C; Moura IC; Demo S; Sarry JE; Recher C; Mayeux P; Tamburini J; Bouscary D
Blood; 2015 Sep; 126(11):1346-56. PubMed ID: 26186940
[TBL] [Abstract][Full Text] [Related]
39. A tale of two glutaminases: homologous enzymes with distinct roles in tumorigenesis.
Katt WP; Lukey MJ; Cerione RA
Future Med Chem; 2017 Jan; 9(2):223-243. PubMed ID: 28111979
[TBL] [Abstract][Full Text] [Related]
40. Recent Progress in the Discovery of Allosteric Inhibitors of Kidney-Type Glutaminase.
Zimmermann SC; Duvall B; Tsukamoto T
J Med Chem; 2019 Jan; 62(1):46-59. PubMed ID: 29969024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
